Need Help?

Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC (Hipo_015)

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD00001010883 Illumina NovaSeq 6000 65
EGAD00001010884 Illumina HiSeq 2000 Illumina HiSeq 2500 32
Publications Citations
Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC.
Nat Cancer 4: 2023 1362-1381
3